Publication | Closed Access

The novel panel assay to define tumor-associated antigen-binding antibodies in patients with metastatic melanomas may have diagnostic value

Tumor ImmunologyMetastatic MelanomasTumor-associated Antigen-binding AntibodiesMedicineMelanomaImmunologyPathologyAntibody ScreeningImmune Checkpoint InhibitorImmunotherapyOncologyNovel Panel AssaySkin Cancer